Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
50 hedge funds and large institutions have $261M invested in Global Cord Blood Corporation in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 15 closing their positions.
118% more capital invested
Capital invested by funds: $119M → $261M (+$141M)
12.83% more ownership
Funds ownership: 8.91% → 21.74% (+13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
4% less funds holding
Funds holding: 52 → 50 (-2)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$3.5M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.94M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$2.49M |
| 4 |
PG
PEAK6 Group
Chicago,
Illinois
|
+$2.3M |
| 5 |
JP Morgan Chase
New York
|
+$1.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Parametrica Management
Wanchai,
Hong Kong
|
-$3.21M |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$2.03M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.88M |
| 4 |
Morgan Stanley
New York
|
-$1.84M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.74M |
CO Hedge Fund Activity: Q4 2017 in Review
50 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2017, worth a combined $261M — up 118% from $119M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of CO and 13 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 14 added.
The largest buyer was Renaissance Technologies, adding an estimated $3.5M. The largest seller was Parametrica Management, cutting an estimated $3.21M.
- 50 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2017, down from 52 in Q3 2017.
- Funds reported $261M of Global Cord Blood Corporation stock for Q4 2017, up 118% quarter-over-quarter.
- 13 funds opened new Global Cord Blood Corporation positions in Q4 2017 and 15 closed out, a net change of -2 holders.
- The largest Global Cord Blood Corporation buyer in Q4 2017 was Renaissance Technologies, an estimated $3.5M added.
- The largest Global Cord Blood Corporation seller in Q4 2017 was Parametrica Management, an estimated $3.21M sold.
Based on aggregated 13F filings for Q4 2017.